Our mission at CIRM is to accelerate stem treatments to patients with unmet medical needs. But what if those needs are not just unmet, they’re also unknown? What happens when those developing treatments never even bother to ask those they are trying to help if this is what they really need, or want? The question … Continue reading How do you know what patients want if you never even ask them?
clinical trials
In the Race to Cure Blindness, Who Will Cross the Finish Line First Optogenetics or Stem Cells?
Before you read this blog, I wanted to share a photo that I took (yes with my iPhone 6…) last week of a beautiful sunset at Ocean Beach in San Francisco. I’m showing you this picture not to gloat that I live by the ocean, but to make a point. You’re able to enjoy this … Continue reading In the Race to Cure Blindness, Who Will Cross the Finish Line First Optogenetics or Stem Cells?
Patients are the Heroes at the CIRM Alpha Stem Cell Clinics Symposium
UCSD’s Catriona Jamieson and patient advocate Sandra Dillon at the CIRM Alpha Clinic Network Symposium Sometimes, when you take a moment to stand back and look at what you have accomplished, you can surprise yourself at how far you have come, and how much you have done in a short space of time. Take the … Continue reading Patients are the Heroes at the CIRM Alpha Stem Cell Clinics Symposium
Rare disease underdogs come out on top at CIRM Board meeting
It seems like an oxymoron but one in ten Americans has a rare disease. With more than 7,000 known rare diseases it’s easy to see how each one could affect thousands of individuals and still be considered a rare or orphan condition. Only 5% of rare diseases have FDA approved therapies People with rare … Continue reading Rare disease underdogs come out on top at CIRM Board meeting
CIRM Alpha Stem Cell Clinics: Paving a Path to Cures
Our mission at CIRM is to accelerate stem cell treatments to patients with unmet medical needs. Over the past ten years, our agency has been tasked with carefully distributing $3 billion dollars of California state tax payer money to the best and brightest scientists in California (and outside too, providing they meet certain requirements). These … Continue reading CIRM Alpha Stem Cell Clinics: Paving a Path to Cures
If you want to accelerate stem cell therapies then create an Accelerating Center
“You can’t teach fish to fly,” is one of the phrases that our CIRM President & CEO, Randy Mills, likes to throw out when asked why we needed to create new centers to help researchers move their most promising therapies out of the lab and into clinical trials. His point is that many researchers are … Continue reading If you want to accelerate stem cell therapies then create an Accelerating Center
Patients beware: warnings about shady clinics and suspect treatments
Every day we get a call from someone seeking help. Some are battling a life-threatening or life-changing disease. Others call on behalf of a friend or loved one. All are looking for the same thing; a treatment, better still a cure, to ease their suffering. Almost every day we have to tell them the same … Continue reading Patients beware: warnings about shady clinics and suspect treatments
What Went Down at ARM’s Regenerative Medicine State of the Industry
Every January, downtown San Francisco is taken over by a flock of investors, bankers, biotech companies, and scientists attending the annual JP Morgan Healthcare Conference. This meeting looks at the healthcare advancements over the past year and predicts the disease areas and technologies that will see the most progress and success in 2016. According to … Continue reading What Went Down at ARM’s Regenerative Medicine State of the Industry
National honor for helping “the blind see”
Those of us fortunate to have good health take so many things for granted, not the least of which is our ability to see. But, according to the World Health Organization, there are 39 million people worldwide who are blind, and another 246 million who are visually impaired. Any therapy, any device, that can help … Continue reading National honor for helping “the blind see”
While You Were Away: Gene Editing Treats Mice with Duchenne Muscular Dystrophy
Welcome back everyone! I hope you enjoyed your holiday and are looking forward to an exciting new year. My favorite thing about coming back from vacation is to see what cool new science was published. Because as you know, science doesn’t take a vacation! As I was reading over the news for this past week, … Continue reading While You Were Away: Gene Editing Treats Mice with Duchenne Muscular Dystrophy